<--- Back to Details
First PageDocument Content
Design of experiments / Medical statistics / Evaluation methods / Pharmacology / Pharmaceutical industry / Cytel / Interim analysis / Clinical trial / Biostatistics / Science / Statistics / Knowledge
Date: 2014-04-17 18:10:28
Design of experiments
Medical statistics
Evaluation methods
Pharmacology
Pharmaceutical industry
Cytel
Interim analysis
Clinical trial
Biostatistics
Science
Statistics
Knowledge

Title: Semi-parametric Joint Modeling of Longitudinal and Survival Data

Add to Reading List

Source URL: www.amstat.org

Download Document from Source Website

File Size: 70,47 KB

Share Document on Facebook

Similar Documents

Chemistry / Mass / Cytel / Science

C ONTRIBUTED R ESEARCH A RTICLES 174 gset: An R Package for Exact Sequential Test of Equivalence Hypothesis Based on

DocID: Vl4R - View Document

Pharmaceutical industry / Medical statistics / Clinical trial / Electronic data capture / Case report form / Interim analysis / Data monitoring committees / EClinical trial technology / Cytel / Clinical Data Management / Research / Clinical research

ICON_White paper_rev_TradeMark

DocID: NaCl - View Document

Infographics / Computational science / Computer graphics / Data visualization / Ggplot2 / Systems visualization / Information visualization / Visualization / Science / Scientific modeling

Data Visualization Using R Sameer Bamnote Cytel Statistical Software & Services Pvt. Ltd., India July 19, 2014

DocID: L6ed - View Document

Extracorporeal membrane oxygenation / Clinical trial / Sequential analysis / Randomization / Estimation theory / Predictive analytics / Cytel / Randomized experiment / Statistics / Design of experiments / Science

Bayesian and “Small n” Trials

DocID: oZZd - View Document

Food and Drug Administration / Respiratory therapy / Technology / SDTM / FEV1/FVC ratio / Pulmonary function testing / Spirometry / Clinical Data Interchange Standards Consortium / Traceability / Respiratory physiology / Statistics / Medicine

PharmaSUG[removed]DS05 Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen Cui, Vertex Pharmaceuticals Incorporated Tathabbai Pakalapati, Cytel Inc.

DocID: nOpM - View Document